Alzheimer's Disease - Pipeline Review, H1 2018 - Product Thumbnail Image

Alzheimer's Disease - Pipeline Review, H1 2018

  • Report
  • 1203 Pages
From
CNS Therapeutics - Global Strategic Business Report - Product Thumbnail Image

CNS Therapeutics - Global Strategic Business Report

  • Report
  • 611 Pages
From
Dementia - Pipeline Review, H1 2018 - Product Thumbnail Image

Dementia - Pipeline Review, H1 2018

  • Report
  • 260 Pages
From
Neurodegenerative Drugs - Global Strategic Business Report - Product Thumbnail Image

Neurodegenerative Drugs - Global Strategic Business Report

  • Report
  • 1108 Pages
From
BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030 - Product Thumbnail Image

BBB Technologies: Novel CNS Drug Delivery Approaches, 2015 - 2030

  • Report
  • 219 Pages
From
Alzheimer's Disease Global Clinical Trials Review, H1, 2017 - Product Thumbnail Image

Alzheimer's Disease Global Clinical Trials Review, H1, 2017

  • Clinical Trials
  • 833 Pages
From
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Cognitive Impairment Disorders Drug Development Pipeline Review, 2018

  • Report
  • 376 Pages
From
Neurodegenerative Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Neurodegenerative Disorders Drug Development Pipeline Review, 2017

  • Report
  • 797 Pages
From
Accera, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis - Product Thumbnail Image

Accera, Inc Company Profile - Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

  • Company Profile
  • 30 Pages
From
  • 9 Results (Page 1 of 1)
Loading Indicator
adroll